Sartorius Aktiengesellschaft (SSSGY)
USD 40.0
(0.0%)
USD 40.0
(0.0%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 6.99 Billion EUR | 62.03% |
| 2022 | 4.31 Billion EUR | 8.57% |
| 2021 | 3.97 Billion EUR | 20.72% |
| 2020 | 3.29 Billion EUR | 86.89% |
| 2019 | 1.76 Billion EUR | 13.49% |
| 2018 | 1.55 Billion EUR | 4.18% |
| 2017 | 1.49 Billion EUR | 46.74% |
| 2016 | 1.01 Billion EUR | 28.23% |
| 2015 | 792.48 Million EUR | 2.21% |
| 2014 | 775.36 Million EUR | 7.07% |
| 2013 | 724.14 Million EUR | 8.54% |
| 2012 | 667.19 Million EUR | 11.61% |
| 2011 | 597.81 Million EUR | 24.4% |
| 2010 | 480.56 Million EUR | -4.11% |
| 2009 | 501.17 Million EUR | -5.73% |
| 2008 | 531.62 Million EUR | 18.18% |
| 2007 | 449.83 Million EUR | 115.84% |
| 2006 | 208.4 Million EUR | -4.44% |
| 2005 | 218.09 Million EUR | -1.06% |
| 2004 | 220.43 Million EUR | -7.09% |
| 2003 | 237.26 Million EUR | -10.21% |
| 2002 | 264.25 Million EUR | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 6.86 Billion EUR | -1.84% |
| 2024 Q2 | 6.13 Billion EUR | -10.73% |
| 2024 Q3 | 6.01 Billion EUR | -1.88% |
| 2023 Q3 | 7.21 Billion EUR | 66.43% |
| 2023 Q2 | 4.33 Billion EUR | -1.61% |
| 2023 Q1 | 4.4 Billion EUR | 2.04% |
| 2023 Q4 | 6.99 Billion EUR | -3.03% |
| 2023 FY | 6.99 Billion EUR | 62.03% |
| 2022 Q3 | 4.58 Billion EUR | 14.31% |
| 2022 FY | 4.31 Billion EUR | 8.57% |
| 2022 Q2 | 4 Billion EUR | 1.06% |
| 2022 Q4 | 4.31 Billion EUR | -5.73% |
| 2022 Q1 | 3.96 Billion EUR | -0.31% |
| 2021 Q3 | 3.97 Billion EUR | 10.83% |
| 2021 Q2 | 3.58 Billion EUR | 0.72% |
| 2021 Q1 | 3.55 Billion EUR | 7.95% |
| 2021 Q4 | 3.97 Billion EUR | 0.17% |
| 2021 FY | 3.97 Billion EUR | 20.72% |
| 2020 Q4 | 3.29 Billion EUR | 12.05% |
| 2020 Q1 | 1.79 Billion EUR | 1.79% |
| 2020 Q2 | 2.69 Billion EUR | 50.06% |
| 2020 Q3 | 2.94 Billion EUR | 9.2% |
| 2020 FY | 3.29 Billion EUR | 86.89% |
| 2019 FY | 1.76 Billion EUR | 13.49% |
| 2019 Q4 | 1.76 Billion EUR | 1.85% |
| 2019 Q3 | 1.73 Billion EUR | 2.05% |
| 2019 Q2 | 1.69 Billion EUR | 0.96% |
| 2019 Q1 | 1.68 Billion EUR | 8.15% |
| 2018 FY | 1.55 Billion EUR | 4.18% |
| 2018 Q2 | 1.57 Billion EUR | 3.44% |
| 2018 Q3 | 1.62 Billion EUR | 3.01% |
| 2018 Q4 | 1.55 Billion EUR | -4.15% |
| 2018 Q1 | 1.52 Billion EUR | 2.01% |
| 2017 Q2 | 1.54 Billion EUR | 3.03% |
| 2017 Q4 | 1.49 Billion EUR | -2.68% |
| 2017 FY | 1.49 Billion EUR | 46.74% |
| 2017 Q1 | 1.49 Billion EUR | 47.52% |
| 2017 Q3 | 1.53 Billion EUR | -0.8% |
| 2016 Q1 | 825.2 Million EUR | 4.13% |
| 2016 FY | 1.01 Billion EUR | 28.23% |
| 2016 Q4 | 1.01 Billion EUR | -2.69% |
| 2016 Q3 | 1.04 Billion EUR | 2.41% |
| 2016 Q2 | 1.01 Billion EUR | 23.57% |
| 2015 Q1 | 734.8 Million EUR | -5.23% |
| 2015 FY | 792.48 Million EUR | 2.21% |
| 2015 Q4 | 792.48 Million EUR | 3.32% |
| 2015 Q3 | 767 Million EUR | 2.84% |
| 2015 Q2 | 745.8 Million EUR | 1.5% |
| 2014 Q2 | 754.4 Million EUR | 5.96% |
| 2014 Q1 | 712 Million EUR | -1.68% |
| 2014 FY | 775.36 Million EUR | 7.07% |
| 2014 Q3 | 757.1 Million EUR | 0.36% |
| 2014 Q4 | 775.36 Million EUR | 2.41% |
| 2013 Q1 | 670.8 Million EUR | 0.54% |
| 2013 Q4 | 724.14 Million EUR | 7.65% |
| 2013 FY | 724.14 Million EUR | 8.54% |
| 2013 Q3 | 672.7 Million EUR | -0.55% |
| 2013 Q2 | 676.4 Million EUR | 0.83% |
| 2012 Q4 | 667.19 Million EUR | 6.24% |
| 2012 FY | 667.19 Million EUR | 11.61% |
| 2012 Q1 | 632.3 Million EUR | 5.77% |
| 2012 Q2 | 641.9 Million EUR | 1.52% |
| 2012 Q3 | 628 Million EUR | -2.17% |
| 2011 Q3 | 512 Million EUR | 1.59% |
| 2011 Q2 | 504 Million EUR | 4.89% |
| 2011 Q1 | 480.5 Million EUR | -0.01% |
| 2011 FY | 597.81 Million EUR | 24.4% |
| 2011 Q4 | 597.81 Million EUR | 16.76% |
| 2010 Q3 | 494.2 Million EUR | -2.66% |
| 2010 Q1 | 521.4 Million EUR | 4.03% |
| 2010 Q4 | 480.56 Million EUR | -2.76% |
| 2010 Q2 | 507.7 Million EUR | -2.63% |
| 2010 FY | 480.56 Million EUR | -4.11% |
| 2009 FY | 501.17 Million EUR | -5.73% |
| 2009 Q4 | 501.17 Million EUR | 0.0% |
| 2008 FY | 531.62 Million EUR | 18.18% |
| 2007 FY | 449.83 Million EUR | 115.84% |
| 2006 FY | 208.4 Million EUR | -4.44% |
| 2005 FY | 218.09 Million EUR | -1.06% |
| 2004 FY | 220.43 Million EUR | -7.09% |
| 2003 FY | 237.26 Million EUR | -10.21% |
| 2002 FY | 264.25 Million EUR | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| American Medical Technologies Inc. | 2.34 Million USD | -297702.748% |
| Ansell Limited | 1.32 Billion USD | -426.195% |
| Ansell Limited | 1.33 Billion USD | -425.21% |
| BG Medicine, Inc. | - USD | -Infinity% |
| Biotage AB (publ) | 126.33 Million USD | -5439.041% |
| BioLife Sciences Inc. | - USD | -Infinity% |
| CB Scientific, Inc. | 943.17 Thousand USD | -741853.748% |
| Psykey, Inc. | 2.47 Million USD | -282755.548% |
| ConvaTec Group Plc | 2.01 Billion USD | -246.749% |
| ConvaTec Group Plc | 2.02 Billion USD | -246.259% |
| Encision Inc. | 1.98 Million USD | -352622.423% |
| Golden Valley Development, Inc | - USD | -Infinity% |
| Hear AtLast Holdings, Inc. | 3.04 Million USD | -230057.814% |
| Innovative MedTech Inc. | 6.13 Million USD | -113968.119% |
| LifePoint, Inc. | 2.45 Million USD | -285043.362% |
| Medite Cancer Diagnostics, Inc. | 10.18 Million USD | -68634.898% |
| Paradigm Medical Industries, Inc. | 3.4 Million USD | -205720.588% |
| QuantRx Biomedical Corporation | - USD | -Infinity% |
| Remedent, Inc. | 3.04 Million USD | -230069.623% |
| Reflect Scientific, Inc. | 776.32 Thousand USD | -901309.068% |
| SmileDirectClub, Inc. | 982.26 Million USD | -612.428% |
| Sector 10, Inc. | 9.84 Million USD | -70977.662% |
| Shandong Weigao Group Medical Polymer Company Limited | 1.35 Billion USD | -416.181% |
| SheerVision, Inc. | 1.43 Million USD | -488783.983% |
| United Health Products, Inc. | 1.99 Million USD | -349992.978% |
| Vasamed, Inc. | 1 Million USD | -696000.666% |
| Wearable Health Solutions, Inc. | 3.8 Million USD | -184041.453% |
| Yubo International Biotech Limited | 2.91 Million USD | -240053.827% |